Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MODAFIMS: An Open-label, Single-center Clinical Trial to Evaluate Predictors of Response to MODAFinil in the Treatment of Cognitive Deficits in Patients With Multiple Sclerosis

NCT06592352 is registered in ClinicalTrials.gov with Clinical Academic Center (2CA-Braga) as lead sponsor.

NCT NCT06592352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06592352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MODAFIMS: An Open-label, Single-center Clinical Trial to Evaluate Predictors of Response to MODAFinil in the Treatment of Cognitive Deficits in Patients With Multiple Sclerosis
Lead sponsor
Clinical Academic Center (2CA-Braga)
Phase
Phase 2
Overall status
Recruiting
Start date
August 27, 2024
Completion date
September 30, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, multiple sclerosis